SecBot SecBot
PRESS-RELEASE ·Filed Mar 19, 2026

MDGL

Madrigal Pharmaceuticals, Inc.
NEUTRAL
Impact 3/10
Horizondays Processed8mo ago WireGlobeNewswire
Press release · Activist
Actionable Insight • Neutral

No immediate trading implications. Monitor for future insider selling from new hires and track Rezdiffra's commercial uptake and Phase 3 outcomes trial data readout.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$441.16
T+0 close · Mar 19, 2026 · via day close
Latest settled
+8.98%
T+60 · $480.77
Vs SPY
−5.44%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Mar 20 $441.16entry
  2. T+1 · 8mo ago +1.49%α +0.38% · $447.72
  3. T+5 · 8mo ago +15.76%α +17.91% · $510.68
  4. T+20 · 7mo ago +19.48%α +10.16% · $527.11
  5. T+60 · 5mo ago +8.98%α −5.44% · $480.77
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Madrigal Pharmaceuticals granted 1,739 restricted stock units to seven new non-executive employees as inducement awards under its 2025 Inducement Plan. The move is a routine hiring incentive and does not reflect material financial or strategic developments.

Key Facts

  • Madrigal granted 1,739 time-based restricted stock units to seven new non-executive employees.
  • Awards were made under the 2025 Inducement Plan and approved by the independent Compensation Committee.
  • RSUs vest in four equal annual installments starting March 15, 2027.
  • Equity grants were material inducements for employment acceptance.
  • No executive-level hires or financial updates were disclosed.

Financial Impact

Minimal dilution, 1,739 RSUs represent less than 0.01% of outstanding shares based on current market cap.

dilutionshare_count

Risk Factors

  • Potential perception of excessive equity use for non-executive roles if trend continues.
  • No direct financial impact, but incremental dilution could concern shareholders if scaled significantly.

Market Snapshot

Exchange
Nasdaq

Investment Themes

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3259422

Track record

18 reports on MDGL

Performance horizon

3 of 6 bullish or bearish reports moved the stock their way by T+5. Best: +10.26% at T+20 after the Jul 30, 2026 report. 3 of 6 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry price pending
  2. Nov 6, 202610d ago SC 13D/A Neutral 3/10 Entry $432.79 to $423.96 Now $423.96 −2.04% ▼ −2.04% −0.35% vs SPY
  3. Nov 6, 202610d ago Insider Buy Bullish 5/10 Entry $432.79 to $423.96 Now $423.96 −2.04% ▼ −2.04% −0.35% vs SPY
  4. Nov 6, 202610d ago Insider Cluster Bullish 5/10 Entry $432.79 to $423.96 Now $423.96 −2.04% ▼ −2.04% −0.35% vs SPY
  5. Nov 6, 202610d ago 144 Neutral 2/10 Entry $432.79 to $423.96 Now $423.96 −2.04% ▼ −2.04% −0.35% vs SPY
  6. Nov 5, 202611d ago Institutional Cluster Mixed 3/10 Entry $400.10 to $425.21 Now $423.96 +5.96% ▲ +6.28% +2.99% vs SPY
  7. Nov 5, 202611d ago Press Release Bullish 5/10 Entry $400.10 to $425.21 Now $423.96 +5.96% ▲ +6.28% +2.99% vs SPY
  8. Nov 3, 202613d ago 8-K Bullish 7/10 No price data
  9. Nov 3, 202613d ago Press Release Bullish 6/10 Entry $396.32 to $432.60 Now $423.96 +6.97% ▲ +9.15% +9.74% vs SPY
  10. Aug 12, 202613w ago 8-K Neutral 3/10 Entry $536.20 to $540.16 Now $423.96 −20.93% ▲ +0.74% +1.18% vs SPY
Showing 10 of 18

US Market Status

Market Closed · Opens Wed (11h 11m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 19, 2026